Welcome to the ATiO Podcast.
...a vibrant hub where we spotlight renowned experts, groundbreaking advancements, and transformative solutions in the world of musculoskeletal therapies. Our platform celebrates noteworthy accomplishments and the respected status of these innovators in our field.
Our podcast aims to do more than just inform. It seeks to captivate and inspire our listeners by sharing the wisdom and journeys of trailblazers and luminaries in the field. Join us as we delve into the depths of innovation and leadership, illuminating the path towards a future of groundbreaking therapies.
As an initiative of the ATiO Foundation, our commitment lies in fostering a community of knowledge and collaboration, where learning and discovery are accessible to all. We believe in the power of education and dialogue to advance the field of musculoskeletal therapies, making significant impacts on health and wellbeing. Embrace this journey with us, where every episode becomes a stepping stone towards a more informed and inspired world.
Listen Now
Recent Episode
Prof. David Hunter — Rethinking Osteoarthritis
In this episode of the ATiO Podcast, we are honored to welcome Prof. David Hunter, a world-renowned leader in osteoarthritis research. As the Florance and Cope Chair of Rheumatology at the University of Sydney and Editor-in-Chief of Osteoarthritis and Cartilage, Professor Hunter has been instrumental in shaping our modern understanding of osteoarthritis.
Our conversation explores the complexity of OA—from disease mechanisms and current treatment strategies to the scientific and clinical challenges that have slowed therapeutic innovation. Professor Hunter shares insights into why osteoarthritis should be understood as a heterogeneous group of conditions, rather than a single disease entity.
We also discuss the role of prevention, lifestyle factors, emerging technologies, and international collaboration in advancing OA care. This episode offers a concise yet compelling look at how rigorous science and global cooperation are redefining the future of osteoarthritis management.